Search results
Augmentin is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1). Acute bacterial sinusitis (adequately diagnosed)
AUGMENTIN is an oral antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium (the potassium salt of clavulanic acid).
Augmentin is an antibiotic agent with a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital. The ß-lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace a wider range of organisms, including many resistant to other ß-lactam antibiotics.
AUGMENTIN oral presentations for twice daily dosing, are indicated for short-term treatment of bacterial infections at the following sites: • Upper respiratory tract infections (including ENT) e.g. tonsillitis, sinusitis, otitis media.
AUGMENTIN oral presentations for twice daily dosing, are indicated for short-term treatment of bacterial infections at the following sites: Upper respiratory tract infections (including ENT) e.g. tonsillitis, sinusitis, otitis media.
Augmentin is an antibiotic. It is used for the short-term treatment of a number of common infections: infections of the respiratory tract (airways and lungs) such as tonsillitis, sinusitis, otitis media (infection of the middle ear), exacerbation (flare up) of bronchitis and pneumonia;
Augmentin is an antibiotic from the group of penicillins. It consists of two active ingredients: Clavulanic acid and Amoxicillin. Clavulanic acid dominates the main immunity or resistance mechanism of numerous resistant bacteria against penicillins and in this way it protects Amoxicillin, which can thus destroy the bacteria.
